Market cap of Blue Water Vaccines Inc. [BWV] reaches 72.56M – now what?


Blue Water Vaccines Inc. [NASDAQ: BWV] surged by $3.11 during the normal trading session on Tuesday and reaching a high of $7.12 during the day while it closed the day at $6.45. The company report on April 21, 2022 that Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today issued the below statement regarding its Form 8-K filed with the Securities and Exchange Commission (“SEC”) on April 20, 2022, which included a presentation (the “WVC presentation”) delivered by the Company at the World Vaccine Congress 2022 in Washington, DC. This presentation by Brian Price, Ph.D., BWV’s Head of Technology Strategy, shows identification of H3N2 and influenza B epitopes of limited variability discovered by scientists at The University of Oxford.

The Company previously presented data surrounding epitopes of limited variability for H1 influenza strains, which are being used to develop BWV-102, an H1 pre-pandemic vaccine. This latest data included in the WVC presentation uses similar mathematical modeling and research to find two epitopes of limited variability in H3N2 influenza and one epitope in influenza B. Provisional patents have been recently filed for both H3 and influenza B antigens by the Company’s licensors and will be used in combination with previously identified H1 epitopes to form the basis for the Company’s universal influenza vaccine candidate, BWV-101.

The market cap for BWV stock reached $72.56 million, with 11.25 million shares outstanding and 4.24 million shares in the current float. Compared to the average trading volume of 670.40K shares, BWV reached a trading volume of 34876577 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Blue Water Vaccines Inc. [BWV]:

The Average True Range (ATR) for Blue Water Vaccines Inc. is set at 3.65 The Price to Book ratio for the last quarter was 7.86, with the Price to Cash per share for the same quarter was set at 0.17.

BWV stock trade performance evaluation

Blue Water Vaccines Inc. [BWV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 55.05.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BWV stock in for the last two-week period is set at 29.92, with the RSI for the last a single of trading hit 32.67, and the three-weeks RSI is set at 31.49 for Blue Water Vaccines Inc. [BWV]. The present Moving Average recorded at 4.22 for the last single week of trading.

Blue Water Vaccines Inc. [BWV]: An insightful look at the core fundamentals

Return on Equity for this stock declined to -110.59, with Return on Assets sitting at -86.55.

Blue Water Vaccines Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.90 and a Current Ratio set at 1.90.